Evolus (EOLS) Liabilities and Shareholders Equity (2017 - 2026)

Evolus' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $220.6 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 3.41% year-over-year to $220.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $894.3 million (down 1.65% YoY) and the FY2025 annual result came in at $225.9 million, down 2.88% from the prior year.
• Liabilities and Shareholders Equity was $220.6 million for Q1 2026 at Evolus, down from $225.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $233.8 million in Q2 2024 and bottomed at $160.2 million in Q1 2023.
• A 5-year average of $207.0 million and a median of $219.0 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity tumbled 30.88% — and 2024, when it surged 41.15%.
• Evolus' Liabilities and Shareholders Equity stood at $178.0 million in 2022, then advanced by 6.19% to $189.0 million in 2023, then rose by 23.05% to $232.6 million in 2024, then dropped by 2.88% to $225.9 million in 2025, then fell by 2.31% to $220.6 million in 2026.
• Business Quant data shows EOLS's Liabilities and Shareholders Equity at $220.6 million in Q1 2026, $225.9 million in Q4 2025, and $219.0 million in Q3 2025.